Chimerix Stock (NASDAQ: CMRX) stock price, news, charts, stock research, profile.
You can purchase shares of Chimerix (NASDAQ:CMRX) through any online brokerage.
Other companies in Chimerix’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Larimar Therapeutics (NASDAQ:LRMR) and Eledon Pharma (NASDAQ:ELDN).
Chimerix has a consensus price target of $7.75.
The stock price for Chimerix (NASDAQ: CMRX) is $3.3 last updated December 24, 2024 at 4:25 PM EST.
There are no upcoming dividends for Chimerix.
Chimerix’s Q4 earnings are confirmed for Thursday, February 27, 2025.
There is no upcoming split for Chimerix.
Chimerix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.